COVID-19大流行期间细胞病理学实验室的状况
The state of cytopathology laboratories during the COVID-19 pandemic.
PubMed 文献 · Cancer Cytopathol · 2020-01-01
本期《Cancer Cytopathology》收录了多篇原创文章、评论和通讯,描述了与大流行对细胞病理学影响相关的广泛主题。
要点
- COVID-19大流行对细胞病理学实验室造成影响
核心结论
- COVID-19大流行对细胞病理学实验室产生了广泛影响。
主要发现
- 医院在应对社区需求时面临挑战,影响波及包括细胞病理学实验室在内的几乎所有领域。
- 本期《Cancer Cytopathology》收录了多篇原创文章、评论和通讯,描述了与大流行对细胞病理学影响相关的广泛主题。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The coronavirus disease 2019 (COVID‐19) pandemic continues to wreak havoc around the world, with a current total of 50.1 million cases of COVID‐19 worldwide and greater than 1.25 million deaths related to the disease. Hospitals have struggled to respond to the needs of their communities, with the pandemic's impact being felt in nearly all areas, including cytopathology laboratories. This issue of Cancer Cytopathology includes several original articles, commentaries, and correspondence describing a wide range of topics related to the effects of the COVID‐19 pandemic on the field of cytopathology.
来源:Cancer Cytopathol,查看原文。版权归原作者所有。
引用
- Faquin WC. The state of cytopathology laboratories during the COVID-19 pandemic. Cancer Cytopathol. 2020. PMID: 33264514. doi:10.1002/cncy.22393
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。